Mounjaro (tirzepatide) is a newer generation of medication designed to target both the GLP-1 and GIP receptors to potentially provide a more comprehensive metabolic effect
Selain memiliki banyak fungsi untuk tubuh, zat ini juga membantu menghambat proses pembentukan melanin sehingga bisa mencerahkan kulit, mencegah dan menunda kerusakan sel
Opdivo's patent is set to expire in 2028, but the exploration of immunotherapy and combination therapies continues
Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction-associated Steatotic Liver Disease: Radiologists' Perspective
ARA-290 interacts with the innate repair receptor (IRR), making it a promising candidate in research related to chronic inflammation, neuropathic pain, and autoimmune conditions
The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023)